My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    HIV-associated adipose redistribution syndrome (HARS): etiology and pathophysiological mechanisms.

    Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E.

    AIDS Res Ther. 2007 Jun 27;4:14.PMID: 17597538 [PubMed]Related articlesFree article

    2.

    Potential of recombinant human growth hormone in HIV-associated adipose redistribution syndrome.

    Torres RA, Cadman JA.

    BioDrugs. 2000 Aug;14(2):83-91.PMID: 18034560 [PubMed]Related articles

    3.

    HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact.

    Lichtenstein K, Balasubramanyam A, Sekhar R, Freedland E.

    AIDS Res Ther. 2007 Jul 16;4:16.PMID: 17634130 [PubMed]Related articlesFree article

    4.

    Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy.

    Grunfeld C, Thompson M, Brown SJ, Richmond G, Lee D, Muurahainen N, Kotler DP; Study 24380 Investigators Group.

    J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):286-97.PMID: 17592343 [PubMed - indexed for MEDLINE]Related articles

    5.

    HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy.

    Fliers E, Sauerwein HP, Romijn JA, Reiss P, van der Valk M, Kalsbeek A, Kreier F, Buijs RM.

    Lancet. 2003 Nov 22;362(9397):1758-60.PMID: 14643128 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pathophysiology of the HIV-Associated Lipodystrophy Syndrome.

    Fève B, Glorian M, Hadri KE.

    Metab Syndr Relat Disord. 2004 Fall;2(4):274-86.PMID: 18370696 [PubMed - in process]Related articles

    7.

    Long-term changes in adipose tissue in human disease.

    Pond CM.

    Proc Nutr Soc. 2001 Aug;60(3):365-74. Review.PMID: 11681811 [PubMed - indexed for MEDLINE]Related articles

    8.

    Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction.

    Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R.

    J Physiol Pharmacol. 2007 Dec;58(4):591-610. Review.PMID: 18195475 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.

    Barbaro G.

    Curr Pharm Des. 2007;13(21):2208-13. Review.PMID: 17627554 [PubMed - indexed for MEDLINE]Related articles

    10.

    Sympathetic nervous system function in HIV-associated adipose redistribution syndrome.

    van Gurp PJ, Tack CJ, van der Valk M, Reiss P, Lenders JW, Sweep FC, Sauerwein HP.

    AIDS. 2006 Mar 21;20(5):773-5.PMID: 16514309 [PubMed - indexed for MEDLINE]Related articles

    11.

    Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.

    Guallar JP, Gallego-Escuredo JM, Domingo JC, Alegre M, Fontdevila J, Martínez E, Hammond EL, Domingo P, Giralt M, Villarroya F.

    AIDS. 2008 Mar 12;22(5):575-84.PMID: 18316998 [PubMed - indexed for MEDLINE]Related articles

    12.

    Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes.

    Yang YK, Chen M, Clements RH, Abrams GA, Aprahamian CJ, Harmon CM.

    Cell Physiol Biochem. 2008;22(5-6):531-8. Epub 2008 Dec 9.PMID: 19088435 [PubMed - indexed for MEDLINE]Related articles

    13.

    GH/GHRH axis in HIV lipodystrophy.

    Stanley TL, Grinspoon SK.

    Pituitary. 2009;12(2):143-52.PMID: 18270841 [PubMed - indexed for MEDLINE]Related articles

    14.

    Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.

    Qureshi K, Abrams GA.

    World J Gastroenterol. 2007 Jul 14;13(26):3540-53. Review.PMID: 17659704 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study.

    Grunfeld C, Rimland D, Gibert CL, Powderly WG, Sidney S, Shlipak MG, Bacchetti P, Scherzer R, Haffner S, Heymsfield SB.

    J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):283-90.PMID: 18167644 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparability of echographic and tomographic assessments of body fat changes related to the HIV associated adipose redistribution syndrome (HARS) in antiretroviral treated patients.

    Gulizia R, Vercelli A, Gervasoni C, Uglietti A, Ortu M, Ferraioli G, Galli M, Filice C.

    Ultrasound Med Biol. 2008 Jul;34(7):1043-8. Epub 2008 Mar 4.PMID: 18308461 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Critical roles of PPARgamma in every aspect of the metabolic syndrome]

    Tanaka T, Masuzaki H, Hosoda K, Nakao K.

    Nippon Rinsho. 2010 Feb;68(2):203-9. Japanese. PMID: 20158085 [PubMed - in process]Related articles

    18.

    Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy.

    Benedini S, Terruzzi I, Lazzarin A, Luzi L.

    BioDrugs. 2008;22(2):101-12. Review.PMID: 18345707 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lipolysis and lipid mobilization in human adipose tissue.

    Lafontan M, Langin D.

    Prog Lipid Res. 2009 Sep;48(5):275-97. Epub 2009 May 21.PMID: 19464318 [PubMed - in process]Related articles

    20.

    Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

    Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S.

    JAMA. 2008 Aug 6;300(5):509-19.PMID: 18677023 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk